Title (en)

DIABETES THERAPY

Title (de)

DIABETESTHERAPIE

Title (fr)

THERAPIE DES DIABETES

Publication

EP 0879279 A4 20000712 (EN)

Application

EP 97905834 A 19970206

Priority

• GB 9603847 A 19960223
• US 9701978 W 19970206
• US 1211196 P 19960206

Abstract (en)

[origin: WO9729180A1] The invention provides a gene therapy method for delivering safe and effective, long-term amounts of GLP-1(7-37)-based proteins useful for treating Type I and Type II diabetes. The invention eliminates the need for subcutaneous injections and is able to provide tight glucose control.

IPC 1-7

C12N 5/00; C12N 15/00; C12N 15/16; C12N 15/09; A61K 48/00

IPC 8 full level

A61K 35/76 (2006.01); A61K 38/00 (2006.01); A61K 48/00 (2006.01); A61P 3/10 (2006.01); C07K 14/605 (2006.01); C12N 5/10 (2006.01); C12N 15/09 (2006.01)

CPC (source: EP)

A61P 3/10 (2017.12); C07K 14/605 (2013.01); A61K 48/00 (2013.01)

Citation (search report)

• [XY] WO 9309222 A2 19930513 - TRANSKARYOTIC THERAPIES INC [US]
• [Y] EP 0619322 A2 19941012 - PFIZER [US]
• [YX] EP 0499990 A2 19920826 - TAKEDA CHEMICAL INDUSTRIES LTD [JP]
• [YX] WO 9503405 A2 19950202 - BIONEBRASKA INC [US]
• See references of WO 9729180A1

Designated contracting state (EPC)

AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

DOCDB simple family (publication)

WO 9729180 A1 19970814; AU 2263197 A 19970828; CA 2243718 A1 19970814; EP 0879279 A1 19981125; EP 0879279 A4 20000712; JP 2001503963 A 20010327

DOCDB simple family (application)

US 9701978 W 19970206; AU 2263197 A 19970206; CA 2243718 A 19970206; EP 97905834 A 19970206; JP 52868597 A 19970206